Advertisement

Der Chirurg

, Volume 78, Issue 12, pp 1085–1090 | Cite as

Peritonealmetastasen in der pathologisch-anatomischen Befundung

  • I. Tischoff
  • A. Tannapfel Email author
Leitthema

Zusammenfassung

Peritonealmetastasen sind sekundäre Tumoren des Peritoneums und stellen die häufigste Tumorentität dieser Lokalisation dar. Tumoren, die typischerweise peritoneal metastasieren, sind das Ovarialkarzinom, das kolorektale Karzinom und das Magenkarzinom neben Karzinomen des Pankreas, der Gallenblase, des Uterus und der Lunge. Von den Peritonealmetastasen abzugrenzen sind die seltenen primären malignen Tumoren des Peritoneums wie das primäre maligne peritoneale Mesotheliom oder das primäre peritoneale Karzinom neben benignen Tumoren des Peritoneums sowie nicht neoplastischen, vorwiegend entzündlichen Veränderungen. Eine Differenzierung zwischen einem primären Tumor des Peritoneums und Peritonealmetastasen ist, insbesondere beim CUP („cancer of unknown primary“) -Syndrom, schwierig und gelingt häufig nur mittels immunhistochemischer Zusatzuntersuchungen.

Schlüsselwörter

Peritonealmetastasen Peritoneales Mesotheliom Primäres peritoneales Karzinom Tumorerkrankung mit unbekanntem Primärtumor Immunhistochemie 

Pathologic and anatomic evidence of peritoneal metastases

Abstract

Peritoneal metastases are secondary tumours of the peritoneum and the most common tumours at this location. Ovarian carcinoma, colorectal cancer, and gastric cancer are the most frequent ones that show peritoneal involvement, along with carcinomas of the pancreas, gallbladder, uterus, and lung. Primary tumours originating in the peritoneum such as malignant peritoneal mesothelioma, primary peritoneal carcinoma, and benign peritoneal tumours along with inflammatory and reactive lesions must be differentiated from peritoneal metastases. Especially in cancer of unknown primary tumour, the discrimination between primary peritoneal tumours and peritoneal metastases is difficult and often requires immunhistochemical identification.

Keywords

Peritoneal metastases Malignant peritoneal mesothelioma Primary peritoneal carcinoma Cancer of unknown primary tumour Immunohistochemistry 

Notes

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Literatur

  1. 1.
    Abbruzzese JL, Abbruzzese MC, Hess KR et al. (1994) Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. J Clin Oncol 12: 1272–1280PubMedGoogle Scholar
  2. 2.
    Antman KH, Corson JM, Li FP et al. (1983) Malignant mesothelioma following radiation exposure. J Clin Oncol 1: 693–700Google Scholar
  3. 3.
    Barnetson RJ, Burnett RA, Downie I et al. (2006) Immunhistochemical analysis of peritoneal mesothelioma and primary and secondary carcinoma of peritoneum: antibodies to estrogen and progesterone receptors are useful. Am J Clin Pathol 125: 67–76PubMedCrossRefGoogle Scholar
  4. 4.
    Bell DA, Scully RE (1990) Serous borderline tumors of the peritoneum. Am J Surg Pathol 14: 230–239PubMedGoogle Scholar
  5. 5.
    Biscotti CV, Hart WR (1992) Peritoneal serous micropapillomatosis of low malignant potential (serous borderline tumors of the peritoneum). Am J Surg Pathol 16: 467–475PubMedCrossRefGoogle Scholar
  6. 6.
    Churg A, Colby TV, Cagle P et al. (2000) The separation of benign and malignant mesothelial proliferations. Am J Surg Pathol 24: 1183–1200PubMedCrossRefGoogle Scholar
  7. 7.
    Clement PB (1994) Diseases of the peritoneum (including endometriosis). In: Kurman RJ (ed) Blaustein‘s pathology of the Female Genital Tract. 4th edn. Springer, New York, pp 647–703Google Scholar
  8. 8.
    Craig JR, Hart WR (1979) Extragenital adenomatoid tumor: Evidence for the mesothelial theory of origin. Cancer 43: 1678–1681PubMedCrossRefGoogle Scholar
  9. 9.
    Dalrymple JC, Russell PBP, Solomon HJ et al. (1989) Extraovarian peritoneal serous papillary carcinoma. A clinicopathological study of 31 cases. Cancer 64: 110–115PubMedCrossRefGoogle Scholar
  10. 10.
    Fann JI, Vierra M, Fisher D, Oberhelman HA Jr (1993) Pseudomyxoma peritonei. Surg Gynecol Obstet 177: 441–447PubMedGoogle Scholar
  11. 11.
    Goldblum J, Hart WR (1995) Localized and diffuse mesotheliomas of the genital tract and peritoneum in women. A clinicopathologic study of nineteen true mesothelial neoplasms, other than adenomatoid tumors, mulitcystic mesotheliomas and localized fibrous tumors. Am J Surg Pathol 19: 1124–1137PubMedCrossRefGoogle Scholar
  12. 12.
    Gonzalez-Moreno S, Yan H, Alcorn KW, Sugarbaker PH (2002) Malignant transformation of „beningn“ cystic mesothelioma of the peritoneum. J Surg Oncol 79: 243–251PubMedCrossRefGoogle Scholar
  13. 13.
    Gough DB, Donohue JH, Schutt AJ et al. (1994) Long-term patient survival with an aggressive regional approach. Ann Surg 29: 112–119Google Scholar
  14. 14.
    Kannerstein M, Churg M (1977) Peritoneal mesothelioma. Hum Pathol 8: 83–94PubMedCrossRefGoogle Scholar
  15. 15.
    Kerrigan SA, Turnnir RT, Clement PB et al. (2002) Diffuse malignant epithelial mesotheliomas of the peritoneum in woman: a clinicpathologic study of patients. Cancer 94: 378–385PubMedCrossRefGoogle Scholar
  16. 16.
    Mayhall FG, Gibbs AR (1991) Malignant peritoneal giving rise to multiple intestinal polyps. Histopathology 20: 47–50CrossRefGoogle Scholar
  17. 17.
    McDonald JC, McDonald AD (1977) Epidemiolgy of mesothelioma from estimated incidence. Prev Med 6: 426–446PubMedCrossRefGoogle Scholar
  18. 18.
    Müller H (2006) Die Hyperthermie im Gesamtkonzept der Behandlung des Bauchfellkrebs. DZO 38: 138–140CrossRefGoogle Scholar
  19. 19.
    Muir C (1995) Cancer of unknown primary site. Cancer [Suppl 1] 75: 353–356Google Scholar
  20. 20.
    Ransom DT, Patel SR, Keeney CL et al. (1990) Papillary serous carcinoma of the peritoneum. A review of 33 cases treated with platin-based chemotherapy. Cancer 66: 1091–1094PubMedCrossRefGoogle Scholar
  21. 21.
    Remmele W (1997) Tumoren des Peritoneums. In: Remmele W (Hrsg) Pathologie. Band III, 2. Aufl. Springer, Berlin Heidelberg New York, S 391–480Google Scholar
  22. 22.
    Riddell RH, Goodman MJ, Moossa AR (1981) Peritoneal malignant mesothelioma in a patient with recurrent peritonitis. Cancer 48: 134–139PubMedCrossRefGoogle Scholar
  23. 23.
    Schorge JO, Muto MG, Lee SJ et al. (2000) BRCA-1 related papillary serous carcinoma of the peritoneum has a unique molecular pathogenesis. Cancer Res 60: 1361–1364PubMedGoogle Scholar
  24. 24.
    Schorge JO, Muto MG, Welch WR et al. (1998) Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA-1 mutations. J Natl Cancer Inst 90: 841–845PubMedCrossRefGoogle Scholar
  25. 25.
    Shanks JH, Harris M, Banerjee SS et al. (2000) Mesotheliomas with deciduoid morphology: a morphologic spectrum and a variant not confined to young femals. Am J Surg Pathol 24: 285–294PubMedCrossRefGoogle Scholar
  26. 26.
    Steffen HM, Wamnbach G, Hoffmann A et al. (1989) Diagnostik und Therapie des malignen peritonealen Mesothelioms. Med Klin 84: 469–473Google Scholar
  27. 27.
    Thor AD, Young RH, Clement PB (1991) Pathology of the Fallopian tube, broad ligamentum, peritoneum and pelvic soft tissue. Hum Pathol 22: 856–867PubMedCrossRefGoogle Scholar
  28. 28.
    Truong LD, Maccato ML, Awalt H et al. (1990) Serous surface carcinoma of the peritoneum: a clinicpathologic study of 22 cases. Hum Pathol 21: 91–110CrossRefGoogle Scholar
  29. 29.
    Van Ruth S, Achermann YIZ, Van de Vijver MJ et al. (2003) Pseudomyxoma peritonei: a review of 62 cases. Eur J Surg Oncol 29: 682–688CrossRefGoogle Scholar
  30. 30.
    Weiss SW, Tavassoli FA (1988) Multicystic mesothelioma. An analysis of pathologic findings and biologic behaviour in 37 cases. Am J Surg Pathol 12: 737–746PubMedCrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag 2007

Authors and Affiliations

  1. 1.Institut für Pathologie der Ruhr-Universität BochumBG Universitätsklinik BergmannsheilBochumDeutschland

Personalised recommendations